Clopidogrel Bisulphate 75mg + Aspirin 75mg is a dual antiplatelet therapy (DAPT) formulation used for the prevention of cardiovascular and thrombotic events. This combination contains Clopidogrel, a P2Y12 platelet inhibitor, and Aspirin, a non-steroidal anti-inflammatory drug (NSAID) with antiplatelet properties. Together, these medicines prevent platelet aggregation and reduce the formation of harmful blood clots. It is commonly prescribed for patients with: Acute coronary syndrome (ACS) Myocardial infarction (heart attack) Ischemic stroke Peripheral arterial disease Post-angioplasty or stent placement This combination significantly lowers the risk of recurrent cardiovascular events and improves long-term cardiac outcomes when used under medical supervision.
